Hu Hongcheng, Pu Yinfei, Lu Songhe, Zhang Kuo, Guo Yuan, Lu Hui, Li Deli, Li Xuefen, Li Zichen, Wu Yuwei, Tang Zhihui
Dental Center, Peking University School and Hospital of Stomatology, Beijing 100101, China.
National Engineering Laboratory for Digital and Material Technology of Stomatology, Peking University School and Hospital of Stomatology, Beijing 100081, China.
Int J Mol Sci. 2015 Oct 20;16(10):24946-64. doi: 10.3390/ijms161024946.
A plastic and biodegradable bone substitute consists of poly (L-lactic-co-glycolic) acid and 30 wt % β-tricalcium phosphate has been previously fabricated, but its osteogenic capability required further improvement. We investigated the use of globular adiponectin (gAPN) as an anabolic agent for tissue-engineered bone using this scaffold. A qualitative analysis of the bone regeneration process was carried out using μCT and histological analysis 12 weeks after implantation. CBCT (Cone Beam Computed Tomography) superimposition was used to characterise the effect of the different treatments on bone formation. In this study, we also explored adiponectin's (APN) influence on primary cultured human jaw bone marrow mesenchymal stem cells gene expressions involved in the osteogenesis. We found OPEN ACCESS Int. J. Mol. Sci. 2015, 16 24947 that composite scaffolds loaded with gAPN or bone morphogenetic protein 2 (BMP2) exhibited significantly increased bone formation and mineralisation following 12 weeks in the extraction sockets of beagle dogs, as well as enhanced expression of osteogenic markers. In vitro investigation revealed that APN also promoted osteoblast differentiation of primary cultured human jaw bone marrow mesenchymal stem cells (h-JBMMSCs), accompanied by increased activity of alkaline phosphatase, greater mineralisation, and production of the osteoblast-differentiated genes osteocalcin, bone sialoprotein and collagen type I, which was reversed by APPL1 siRNA. Therefore, the composite scaffold loaded with APN exhibited superior activity for guided bone regeneration compared with blank control or Bio-Oss® (a commercially available product). The composite scaffold with APN has significant potential for clinical applications in bone tissue engineering.
一种由聚(L-乳酸-共-乙醇酸)和30 wt%β-磷酸三钙组成的可塑且可生物降解的骨替代物此前已被制备出来,但其成骨能力仍需进一步提高。我们研究了使用球状脂联素(gAPN)作为这种支架用于组织工程骨的合成代谢剂。在植入12周后,使用μCT和组织学分析对骨再生过程进行了定性分析。采用锥形束计算机断层扫描(CBCT)叠加来表征不同处理对骨形成的影响。在本研究中,我们还探讨了脂联素(APN)对原代培养的人颌骨骨髓间充质干细胞参与成骨的基因表达的影响。我们发现,负载gAPN或骨形态发生蛋白2(BMP2)的复合支架在比格犬拔牙窝植入12周后,骨形成和矿化显著增加,同时成骨标志物的表达增强。体外研究表明,APN还促进了原代培养的人颌骨骨髓间充质干细胞(h-JBMMSCs)向成骨细胞的分化,伴随着碱性磷酸酶活性增加、矿化增强以及成骨细胞分化基因骨钙素、骨唾液蛋白和I型胶原蛋白的产生,而APPL1 siRNA可逆转这种作用。因此,与空白对照或Bio-Oss®(一种市售产品)相比,负载APN的复合支架在引导骨再生方面表现出卓越的活性。含APN的复合支架在骨组织工程临床应用中具有巨大潜力。